A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens-Reference-Cited by-同舟云学术

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens

Published:2017-06-19 Issue:7 Volume:127 Page:2705-2718
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Chang Aaron Y.,Dao Tao,Gejman Ron S.,Jarvis Casey A.,Scott Andrew,Dubrovsky Leonid^ORCID,Mathias Melissa D.,Korontsvit Tatyana,Zakhaleva Victoriya,Curcio Michael,Hendrickson Ronald C.,Liu Cheng,Scheinberg David A.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/92335/files/pdf

Reference61 articles.

1. Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia;Wadelin;Mol Cancer,2010

2. Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

3. A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer;Epping;Cancer Res,2006

4. The Tumor-Associated Antigen PRAME Is Universally Expressed in High-Stage Neuroblastoma and Associated with Poor Outcome

5. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V;Biomolecules and Biomedicine;2024-09-06

2. Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding;Journal of Biological Chemistry;2024-09

3. T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma;Pharmaceutics;2024-08-06

4. The Future of TCR-like Antibodies in Diagnosis and Potential Application Targets;Current Molecular Medicine;2024-05-27

5. Targeting PRAME for acute myeloid leukemia therapy;Frontiers in Immunology;2024-03-26